Enochian Biosciences Inc.

NASDAQ: ENOB · Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM

Enochian Biosciences Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-80.65M -39,684.1B -113.43M -26.72M
Depreciation & Amortization
121.86K 113.5B 123.59K 391.42K
Stock-Based Compensation
4.67M 3,535.1B 5.49M 1.44M
Other Working Capital
n/a -3,895B 333.8K 1.2M
Other Non-Cash Items
n/a 24,261B 90.67M 3.34M
Deferred Income Tax
n/a -3,895B n/a n/a
Change in Working Capital
n/a 3,895B 1.42M 932.13K
Operating Cash Flow
-10.97M -11,774.5B -15.73M -20.61M
Capital Expenditures
-70.43K -29.77B -5.16K -48.89K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-1.19M n/a n/a n/a
Investing Cash Flow
-1.26M -29.77B -5.16K -48.89K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.52M 4,515.1B 4,250.5B 32.6M
Financial Cash Flow
10.52M 4,515.1B 4.25M 32.6M
Net Cash Flow
-1.65M -7,297.7B -11.49M 11.97M
Free Cash Flow
-11.04M -11,804.3B -15.74M -20.66M